Looking Ahead

Our vision is to build a portfolio of premium products inspired by microbiome research – tailored to the evolving needs of people on modern health journeys.

The gut microbiome is a vast, largely untapped frontier. Forte80 is only the beginning. At Azento Health, we are building a portfolio of products designed to accompany people throughout their entire GLP-1 journey – before, during, and after treatment.

Before

When someone begins a weight-loss journey, preparing the body and mind is key. Future opportunities include:

During

The active phase of GLP-1 therapy brings both progress and challenges. Here, we see opportunities to innovate:

After

Sustaining results is just as important as achieving them. In the post-GLP-1 phase, future products may include:

Beyond

Our ambition goes beyond individual products. We aim to:

At Azento Health, we see the gut microbiome as a key frontier in modern health. By innovating across the consumer journey – before, during, and after GLP-1 treatment – we are creating a new standard at the intersection of science, lifestyle, and wellbeing.

By combining Swiss quality, microbiome innovation, and patient-focused design, Azento Health aims to become a leader in this category.